Somatoform Disorders: Clinical Trials

6 trials for Somatoform Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 6

Follow Somatoform Disorders: new trials by email Literature Review of Somatoform Disorders trials Research Report on Somatoform Disorders

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients
Dexamethasone tapering dose, Dexamethasone physician choice - Early-stage Breast Cancer, Pain Syndrome
Phase 4CompletedOttawa Hospital Research Institute1242018-02-282020-01-09
Treating Emotional Disorders in Primary Care With Psychological Techniques
Cognitive Behavioral Treatment, Primary Care Treatment As Usual - Anxiety Disorders, Mood Disorders
Phase 4CompletedPsicofundación: Fundación Española para Promoción, Desarrollo Científico y Profesional de la Psicolo11262014-01-142020-03-10
Treatment Trial for Psychogenic Nonepileptic Seizures
sertraline, CBT-ip, Combined (sertraline + CBT-ip) - Convulsion, Non-Epileptic, Conversion Disorder
Phase 4CompletedRhode Island Hospital382008-09-012014-11-10
Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder
Levetiracetam - Body Dysmorphic Disorder
Phase 4CompletedButler Hospital172004-12-012019-08-29
Fluoxetine in Pediatric Body Dysmorphic Disorder
Fluoxetine, Placebo - Body Dysmorphic Disorder
Phase 4CompletedMontefiore Medical Center432004-11-012018-04-27
Treatments for Psychogenic Nonepileptic Seizures (NES)
sertraline, placebo - Convulsion, Non-Epileptic, Conversion Disorder
Phase 4CompletedRhode Island Hospital382003-12-012014-11-20

Narrower conditions

Anxiety Disorders (2)  ·  Body Dysmorphic Disorders (2)  ·  Conversion Disorder (2)  ·  Depression (2)  ·  Psychogenic Nonepileptic Seizures (2)  ·  Seizures (2)  ·  Stress Disorders, Post-Traumatic (2)  ·  Breast Neoplasms (1)  ·  Depressive Disorder, Major (1)  ·  Dissociative Disorders (1)  ·  Dysthymic Disorder (1)  ·  Generalized Anxiety Disorder (1)  ·  Mood Disorders (1)  ·  Panic Disorder (1)

Broader conditions

Mental Disorders (6)  ·  Behavior (2)  ·  Behavioral Symptoms (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Stress Disorders, Traumatic (2)  ·  Trauma and Stressor Related Disorders (2)  ·  Breast Diseases (1)  ·  Depressive Disorder (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Phobic Disorders (1)

Interventions

Sertraline (2)  ·  Acetaminophen (1)  ·  Antidepressive Agents (1)  ·  Fluoxetine (1)  ·  Levetiracetam (1)  ·  Sleep (1)  ·  Standard of Care (1)  ·  dexamethasone 21-phosphate (1)  ·  dexamethasone acetate (1)

Sponsors

Rhode Island Hospital (2)  ·  Butler Hospital (1)  ·  Montefiore Medical Center (1)  ·  Ottawa Hospital Research Institute (1)  ·  Psicofundación: Fundación Española para Promoción, Desarrollo Científico y Profesional de la Psicolo (1)

Countries

United States (4)  ·  Canada (1)  ·  Spain (1)

Top investigators

W. Curt LaFrance, Jr., MD, MPH (2)  ·  Antonio R Cano-Vindel, Professor (1)  ·  Eric Hollander, MD (1)  ·  Katharine A Phillips, M.D. (1)  ·  Mark Clemons, MD (1)

Results publications

PMID 18070841, PMID 19652140, PMID 20739647, PMID 24989152, PMID 33742240

NIH funding

K23NS045902 (1)